Submitted by Aspergillus Administrator on 28 January 2012
|
Saturday 28 January 2012 – Day 3
|
08.00 – 08.45 Meet the Professor
Stump the Professor – Interesting clinical dilemmas
John E. Bennett, MD
Souha Kanj, MD
Session 9: Diagnostics and Imaging
Chairs: Dimitrios P. Kontoyiannis, MD & Malcolm Richardson, PhD
Chairs: Dimitrios P. Kontoyiannis, MD & Malcolm Richardson, PhD
09.15 – 09.40 Application of diagnostic markers for IA in children
Emmanuel Roilides, MD
09.40 – 10.05 Impact of prophylaxis on galactomannan, beta-D-glucan and PCR
J. Peter Donnelly, PhD
10.05 – 10.30 Which antigens are important and why?
Max S. Topp, MD
10.30 – 10.40 Oral Poster Presentation: Impact of current antifungal therapy on PCR based investigation of bronchoalveolar lavage samples for diagnosing pulmonary aspergillosis in patients with hematologic malignanciesMark Reinwald, MD
Session 10: Pfizer Symposium
The Treatment Options Strategies for IAChairman: J. Peter Donnelly, PhD
The Treatment Options Strategies for IAChairman: J. Peter Donnelly, PhD
11.10 – 11.15 Welcome and introduction
J. Peter Donnelly, PhD
11.15 – 11.30 Stratification of risk for IA in immunocompromised patients
Raoul Herbrecht, MD
11.20 – 11.45 Pre-emptive versus empirical anti-fungal therapy in neutropenic hematologic patients
Omrum Uzun, MD
11.45 – 12.00 Combination therapy: who benefits?
Keiren Marr, MD
12.00 – 12.10 Panel discussion
Session 11: Antifungal Resistance
Chairs: David A. Stevens, MD & Beyza Ener, MD
Chairs: David A. Stevens, MD & Beyza Ener, MD
14.10 – 14.35 Global status of azole resistance in Europe and Asia
Sevtap Arikan-Akdagli, MD
14.35 – 15.00 Update on resistance mechanisms
David S. Perlin, PhD
15.00 – 15.10 Oral Poster Presentation: Aspergillus fumigatus biofilms releases extracellular DNA which plays a role in phase dependant antifungal resistance
Ranjith Rajendran, MSc
15.10 – 15.35 Current section and species complex concepts: recommendations for routine daily practice
Manuel Cuenca-Estrella, MD, PhD
15.35 – 16.00 Implications of resistance in Aspergillus treatment guidelines
Dimitrios P. Kontoyiannis, MD
16.00 – 16.10 Farewell
David A. Stevens, MD
16.20 Farewell Drinks and Discussion about the next AAA Meeting
News archives
Showing 10 posts of 953 posts found.
-
Title
Date
